- CA$21.80m
- CA$25.52m
Annual income statement for ReGen III, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4.6 | 3.12 | 3.84 | 12.6 | 5.7 |
Operating Profit | -4.6 | -3.12 | -3.84 | -12.6 | -5.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -5.97 | -4.74 | -4.73 | -12.5 | -5.81 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.97 | -4.74 | -4.73 | -12.5 | -5.65 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.97 | -4.74 | -4.73 | -12.5 | -5.65 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.97 | -4.74 | -4.73 | -12.5 | -5.65 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.081 | -0.052 | -0.102 | -0.11 | -0.047 |